#	Pagina
attuale pagina	/open-h2020/projects/207220/index.html

Opendata, web and dolomites

SPIDIA4P SIGNED

SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

SPIDIA4P project word cloud

Explore the words cloud of the SPIDIA4P project. It provides you a very rough idea of what is the project "SPIDIA4P" about.

diagnosis corresponding international 22 smes schemes impacts disease iso diagnostic limited counselling survey workflows action molecular involvements quality spida4p reunites personalized proposes medicine personalised compromised prognosis biomedical cellular collection spidia4p obtain ing maximise eqa balanced profiles guidelines external improvements patient extra coming specifications 19 moment samples cen empowered allowed generate stakeholder patients closely transport standards discovery unreliable outcome education industry tackle coordinate applicable official serving portfolio storage biobanks progress foci analytical preservation public pan stratification diagnostics organisation training assurance additional data biomolecules private insufficient post standardisation vitro impossible validation biomarker workflow

Project "SPIDIA4P" data sheet

The following table provides information about the project.

Coordinator	QIAGEN GMBH Organization address address: QIAGEN STRASSE 1 city: HILDEN postcode: 40724 website: www.qiagen.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Germany [DE]
Project website	http://www.spidia.eu/
Total cost	2˙079˙053 €
EC max contribution	1˙999˙972 € (96%)
Programme	1. H2020-EU.3.1.6. (Health care provision and integrated care)
Code Call	H2020-SC1-2016-RTD
Funding Scheme	CSA
Starting year	2017
Duration (year-month-day)	from 2017-01-01 to 2020-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	QIAGEN GMBH QIAGEN GMBH Organization address address: QIAGEN STRASSE 1 city: HILDEN postcode: 40724 website: www.qiagen.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (HILDEN)	coordinator	372˙831.00
2	DIN DEUTSCHES INSTITUT FUER NORMUNG E.V. DIN DEUTSCHES INSTITUT FUER NORMUNG E.V. Organization address address: BURGGRAFENSTRASSE 6 city: BERLIN postcode: 10787 website: www.din.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (BERLIN)	participant	199˙625.00
3	MEDIZINISCHE UNIVERSITAT GRAZ MEDIZINISCHE UNIVERSITAT GRAZ Organization address address: AUENBRUGGERPLATZ 2 city: GRAZ postcode: 8036 website: http://www.medunigraz.at contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (GRAZ)	participant	158˙318.00
4	LUXEMBOURG INSTITUTE OF HEALTH LUXEMBOURG INSTITUTE OF HEALTH Organization address address: VAL FLEURI 84 city: LUXEMBOURG postcode: 1526 website: https://www.lih.lu/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	LU (LUXEMBOURG)	participant	152˙500.00
5	ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM Organization address address: DR MOLEWATERPLEIN 40 city: ROTTERDAM postcode: 3015 GD website: www.erasmusmc.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (ROTTERDAM)	participant	118˙750.00
6	UNIVERSITA DEGLI STUDI DI FIRENZE UNIVERSITA DEGLI STUDI DI FIRENZE Organization address address: Piazza San Marco 4 city: Florence postcode: 50121 website: http://www.unifi.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (Florence)	participant	102˙875.00
7	TECHNISCHE UNIVERSITAET MUENCHEN TECHNISCHE UNIVERSITAET MUENCHEN Organization address address: Arcisstrasse 21 city: MUENCHEN postcode: 80333 website: www.tu-muenchen.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (MUENCHEN)	participant	100˙875.00
8	BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC) BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC) Organization address address: NEUE STIFTINGTALSTRASSE 2/B/6 city: GRAZ postcode: 8010 website: www.bbmri-eric.eu contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (GRAZ)	participant	100˙673.00
9	CAMBRIDGE PROTEIN ARRAYS LTD CAMBRIDGE PROTEIN ARRAYS LTD Organization address address: BABRAHAM HALL, BABRAHAM RESEARCH CAMPUS city: CAMBRIDGE postcode: CB22 3AT website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (CAMBRIDGE)	participant	97˙000.00
10	FUNDACIO CENTRE DE REGULACIO GENOMICA FUNDACIO CENTRE DE REGULACIO GENOMICA Organization address address: CARRER DOCTOR AIGUADER 88 city: BARCELONA postcode: 8003 website: www.crg.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	88˙750.00
11	UNIVERSITA DEGLI STUDI DI TRIESTE UNIVERSITA DEGLI STUDI DI TRIESTE Organization address address: PIAZZALE EUROPA 1 city: TRIESTE postcode: 34127 website: www.units.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (TRIESTE)	participant	84˙750.00
12	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Organization address address: RUE DE TOLBIAC 101 city: PARIS postcode: 75654 website: www.inserm.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	82˙750.00
13	UNIVERSITA DEGLI STUDI DI TORINO UNIVERSITA DEGLI STUDI DI TORINO Organization address address: VIA GIUSEPPE VERDI 8 city: TORINO postcode: 10124 website: www.unito.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (TORINO)	participant	78˙375.00
14	TATAA BIOCENTER AB TATAA BIOCENTER AB Organization address address: ODINSGATAN 28 city: GOTEBORG postcode: 411 03 website: www.tataa.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (GOTEBORG)	participant	75˙875.00
15	LGC LIMITED LGC LIMITED Organization address address: QUEENS ROAD city: TEDDINGTON postcode: TW11 0LY website: www.lgc.co.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (TEDDINGTON)	participant	73˙398.00
16	CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLO PROTEINE CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLO PROTEINE Organization address address: PIAZZA SAN MARCO 4 city: FIRENZE postcode: 50121 website: www.cerm.unifi.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (FIRENZE)	participant	61˙375.00
17	FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI Organization address address: Via Venezian 1 city: Milan postcode: 20133 website: www.istitutotumori.mi.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (Milan)	participant	51˙250.00
18	INIVATA LIMITED INIVATA LIMITED Organization address address: LI KA SHING CENTRE ROBINSON WAY city: CAMBRIDGE postcode: CB2 0RE website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (CAMBRIDGE)	participant	0.00
19	PREANALYTIX GMBH PREANALYTIX GMBH Organization address address: FELDBACHSTRASSE city: HOMBRECHTIKON postcode: 8634 website: www.preanalytix.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (HOMBRECHTIKON)	participant	0.00

Map

Project objective

Molecular in vitro diagnostics and biomedical research have allowed great progress in personalised medicine but further progress is limited by insufficient guidelines for pre-analytical workflow steps (sample collection, preservation, storage, transport, processing etc.) as well as by insufficient quality assurance of diagnostic practice. This allows using compromised patients’ samples with post collection changes in cellular and extra-cellular biomolecules’ profiles thus often making diagnostic test results unreliable or even impossible. To tackle this, SPIDA4P aims to generate and implement a comprehensive portfolio of 22 pan-European pre-analytical CEN/Technical Specifications and ISO/International Standards, addressing the important pre-analytical workflows applied to personalized medicine. These will also applicable to biomarker discovery, development and validation as well as to biobanks. Corresponding External Quality Assurance (EQA) Schemes will be developed and implemented as well, aiming to survey the resulting quality of samples and diagnostic practice. SPIDIA4P will ensure stakeholder organisations involvements as well as training, education, and counselling as additional major foci of the project. The consortium will closely coordinate with large European public research consortia to obtain access to research and validation studies data serving as evidence for the new standards developments and achieved improvements of diagnosis, patient stratification and prognosis of disease outcome. At this crucial moment in the development of personalised medicine, SPIDIA4P proposes a coordination and support action that reunites 19 highly experienced partners in international standardisation for in vitro diagnostics, coming from private industry including SMEs, public institutions and from one official European Standards Organisation. This strong consortium is balanced and empowered to maximise the impacts of in vitro diagnostics on personalised medicine.

Deliverables

List of deliverables.
Newsletter of SPIDIA4P (M12)	Websites, patent fillings, videos etc.	2020-03-17 14:15:00
Definition of the communication campaign and reviewed (M12)	Documents, reports	2020-03-17 14:15:00
Statistics, summary of incidents and measures taken published in the public domain (M18)	Documents, reports	2020-03-17 14:15:00
Sub section for SPIDIA4P established on the SPIDIA website	Websites, patent fillings, videos etc.	2020-03-17 14:15:00

Take a look to the deliverables list in detail: detailed list of SPIDIA4P deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2017	Marika Doucet, Karl Friedrich Becker, Jens BjÃ¶rkman, Jacques Bonnet, Bruno ClÃ©ment, Maria-Grazia Daidone, Charles Duyckaerts, Gilles Erb, Helmuth Haslacher, Paul Hofman, Berthold Huppertz, Christophe Junot, Joakim Lundeberg, Andres Metspalu, Marialuisa Lavitrano, Jan-Eric Litton, Helen M. Moore, Manuel Morente, Ben-Youssef Naimi, Uwe Oelmueller, Bill Ollier, Barbara Parodi, Liangliang Ruan, Gior Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking published pages: 270-276, ISSN: 1947-5535, DOI: 10.1089/bio.2016.0053	Biopreservation and Biobanking 15/3	2020-03-17
2019	P.H.J. Riegman, K.F. Becker, K. Zatloukal, M. Pazzagli, U. SchrÃ¶der, U. Oelmuller How standardization of the pre-analytical phase of both research and diagnostic biomaterials can increase reproducibility of biomedical research and diagnostics published pages: 35-40, ISSN: 1871-6784, DOI: 10.1016/j.nbt.2019.06.007	New Biotechnology 53	2020-03-17
2019	Veronica Ghini, Deborah Quaglio, Claudio Luchinat, Paola Turano NMR for sample quality assessment in metabolomics published pages: 25-34, ISSN: 1871-6784, DOI: 10.1016/j.nbt.2019.04.004	New Biotechnology 52	2020-03-17
2020	Heimo MÃ¼ller, Georges Dagher, Martina Loibner, Cornelia Stumptner, Penelope Kungl, Kurt Zatloukal Biobanks for life sciences and personalized medicine: importance of standardization, biosafety, biosecurity, and data management published pages: 45-51, ISSN: 0958-1669, DOI: 10.1016/j.copbio.2019.12.004	Current Opinion in Biotechnology 65	2020-03-17
2018	Michael J. Taussig, ClÃ¡udia Fonseca, James S. Trimmer Antibody validation: a view from the mountains published pages: 1-8, ISSN: 1871-6784, DOI: 10.1016/j.nbt.2018.08.002	New Biotechnology 45	2020-03-17
2019	Georges Dagher, Karl-Friedrich Becker, Serena Bonin, Carole Foy, Stefania Gelmini, Mikael Kubista, Penelope Kungl, Uwe Oelmueller, Helen Parkes, Pamela Pinzani, Peter Riegman, Ulrike SchrÃ¶der, Cornelia Stumptner, Paola Turano, Robert SjÃ¶back, Andrea Wutte, Kurt Zatloukal Pre-analytical processes in medical diagnostics: New regulatory requirements and standards published pages: 121-125, ISSN: 1871-6784, DOI: 10.1016/j.nbt.2019.05.002	New Biotechnology 52	2020-03-17
2019	Cornelia Stumptner, Daniela Pabst, Martina Loibner, Christian Viertler, Kurt Zatloukal The impact of crosslinking and non-crosslinking fixatives on antigen retrieval and immunohistochemistry published pages: 69-83, ISSN: 1871-6784, DOI: 10.1016/j.nbt.2019.05.003	New Biotechnology 52	2020-03-17
2020	Serena Bonin, Giorgio Stanta Pre-analytics and tumor heterogeneity published pages: 30-35, ISSN: 1871-6784, DOI: 10.1016/j.nbt.2019.09.007	New Biotechnology 55	2020-03-17
2020	Olga Kofanova, Camille Bellora, Sonia Garcia Frasquilho, Laurent Antunes, Gael Hamot, Conny Mathay, Kathleen Mommaerts, Arnaud Muller, Brian DeWitt, Fay Betsou Standardization of the preanalytical phase of DNA extraction from fixed tissue for next-generation sequencing analyses published pages: 52-61, ISSN: 1871-6784, DOI: 10.1016/j.nbt.2019.07.005	New Biotechnology 54	2020-03-17
2019	Laura Annaratone, Caterina MarchiÃ², Anna Sapino Tissues under-vacuum to overcome suboptimal preservation published pages: 104-109, ISSN: 1871-6784, DOI: 10.1016/j.nbt.2019.05.007	New Biotechnology 52	2020-03-17
2019	Wim Ammerlaan, Fay Betsou Biospecimen Science of Blood for cfDNA Genetic Analyses published pages: 9-15, ISSN: 2167-485X, DOI: 10.1007/s40139-019-00193-7	Current Pathobiology Reports 7/2	2020-03-17
2018	Kurt Zatloukal, Cornelia Stumptner, Penelope Kungl, Heimo Mueller Biobanks in personalized medicine published pages: 265-273, ISSN: 2380-8993, DOI: 10.1080/23808993.2018.1493921	Expert Review of Precision Medicine and Drug Development 3/4	2020-03-17
2017	Martina Loibner, Lisa Oberauner-Wappis, Christian Viertler, Daniel Groelz, Kurt Zatloukal Protocol for HER2 FISH Using a Non-cross-linking, Formalin-free Tissue Fixative to Combine Advantages of Cryo-preservation and Formalin Fixation published pages: Video article, ISSN: 1940-087X, DOI: 10.3791/55885	Journal of Visualized Experiments 130	2020-03-17

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SPIDIA4P" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SPIDIA4P" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.6.)

EBRA (2018)

European Brain Research Area

SAPHIRE (2018)

Securing Adoption of Personalised Health in REgions

HTx (2019)

Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe